Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.
2.

Racial differences in adenocarcinoma of the prostate in North American men.

Morton RA Jr.

Urology. 1994 Nov;44(5):637-45. Review.

PMID:
7526522
3.

Screening for prostate cancer in African Americans.

Moul JW.

Curr Urol Rep. 2000 May;1(1):57-64. Review.

PMID:
12084342
4.

Racial differences in prostate cancer treatment outcomes: a systematic review.

Peters N, Armstrong K.

Cancer Nurs. 2005 Mar-Apr;28(2):108-18. Review.

PMID:
15815180
5.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
6.

Race and serum prostate-specific antigen levels: current status and future directions.

Abdalla I, Ray P, Vijayakumar S.

Semin Urol Oncol. 1998 Nov;16(4):207-13. Review.

PMID:
9858327
7.

Impact of screening on incidence and mortality of prostate cancer in the United States.

Potosky AL, Feuer EJ, Levin DL.

Epidemiol Rev. 2001;23(1):181-6. Review.

PMID:
11588846
8.
9.

Impact of screening on prostate cancer rates and trends.

Mettlin C.

Microsc Res Tech. 2000 Dec 1;51(5):415-8. Review.

PMID:
11074610
10.

Epidemiology and pathophysiology of prostate cancer in African-American men.

Powell IJ.

J Urol. 2007 Feb;177(2):444-9. Review.

PMID:
17222606
11.

Practice of opportunistic PSA screening in the Florence District.

Zappa M, Visioli C, Crocetti E, Buonamici C, Baccini A, Taddei S, Ciatto S.

Eur J Cancer Prev. 2003 Jun;12(3):201-4. Review.

PMID:
12771558
12.

The epidemiology of prostate cancer part I: descriptive epidemiology.

Brawley OW, Knopf K, Merrill R.

Semin Urol Oncol. 1998 Nov;16(4):187-92. Review.

PMID:
9858324
13.
14.

Prostate cancer: A challenge for screening.

Donnell RF.

Surg Oncol Clin N Am. 1999 Oct;8(4):693-702, vii. Review.

PMID:
10452935
15.

Explaining racial differences in prostate cancer in the United States: sociology or biology?

Freedland SJ, Isaacs WB.

Prostate. 2005 Feb 15;62(3):243-52. Review.

PMID:
15389726
16.

Prostate cancer and black men.

Brawley OW.

Semin Urol Oncol. 1998 Nov;16(4):184-6. Review.

PMID:
9858323
17.

Clinical inquiries. Is prostate-specific antigen (PSA) screening indicated for any subgroup of men?

Fisher M, Beck E.

J Fam Pract. 2002 Feb;51(2):113. Review. No abstract available.

PMID:
11978206

Supplemental Content

Support Center